Pulmonary Hypertension Clinical Trials

Find Pulmonary Hypertension Clinical Trials Near You

The Benefits of Home Exercise in Pulmonary Hypertension Interstitial Lung Disease

Status: Recruiting
Location: See location...
Intervention Type: Behavioral
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

This study evaluates the effects of a structured home exercise program in participants with pulmonary hypertension associated with interstitial lung disease. Participants will complete a defined exercise regimen over a 16-week period, and functional capacity and patient reported outcomes will be assessed at baseline and after the intervention. The study aims to determine whether a home-based exercise approach is feasible and associated with improvements in functional performance.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Follows at University of Rochester Medical Center Pulmonary Hypertension Clinic.

• Adult patients (\>18 years old) with right heart catheterization confirmed pulmonary hypertension interstitial lung disease on stable therapy dosing for at least 30 days.

• Access to a smart phone or email to receive daily messages.

• Clinically stable by the investigator.

Locations
United States
New York
University of Rochester Medical Center
RECRUITING
Rochester
Contact Information
Primary
Daniel Lachant, DO
Daniel_Lachant@urmc.rochester.edu
585 273 4608
Time Frame
Start Date: 2026-07-15
Estimated Completion Date: 2027-05-30
Participants
Target number of participants: 30
Treatments
Experimental: Aerobic Plus Strength Training
Participants receive 16 weeks of structured daily exercise messages for aerobic and strength training activities with heart rate guidance. Participants also receive resistance bands and ankle weights.
Active_comparator: Aerobic only
Participants receive 16 weeks of structured daily aerobic exercise messages with heart rate guidance. Participants may perform walking or Cubii-based aerobic exercise.
Sponsors
Collaborators: Liquidia Technologies, Inc.
Leads: University of Rochester

This content was sourced from clinicaltrials.gov